Moreover, HIF levels are characteristically low in IDH mutant gliomas (91), and deletion of HIF1 can augment brain tumor growth in mouse models, suggesting that decreased HIF1 activity contributes to gliomagenesis (92). The gene discussed is SETD2; the disease is central nervous system cancer.